These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 19309552)
21. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients. Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955 [TBL] [Abstract][Full Text] [Related]
22. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients]. Bilińska M; Frydecka I; Podemski R Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716 [TBL] [Abstract][Full Text] [Related]
23. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy. Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984 [TBL] [Abstract][Full Text] [Related]
24. [Soluble interleukin-2 receptor in patients with urinary bladder cancer]. Wen R; Xie S Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):224-6. PubMed ID: 9387261 [TBL] [Abstract][Full Text] [Related]
25. Alterations of Fas and Fas-related molecules in patients with silicosis. Otsuki T; Miura Y; Nishimura Y; Hyodoh F; Takata A; Kusaka M; Katsuyama H; Tomita M; Ueki A; Kishimoto T Exp Biol Med (Maywood); 2006 May; 231(5):522-33. PubMed ID: 16636300 [TBL] [Abstract][Full Text] [Related]
26. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B]. Pawłowska M; Halota W; Smukalska E; Grabczewska E Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543 [TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]. Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038 [TBL] [Abstract][Full Text] [Related]
28. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls. Sivieri S; Ferrarini AM; Gallo P Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585 [TBL] [Abstract][Full Text] [Related]
29. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
30. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus. Raziuddin S; al-Janadi MA; al-Wabel AA J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190 [TBL] [Abstract][Full Text] [Related]
31. [Changes of interleukin-2 and soluble interleukin-2 receptor serum level and multiple organ dysfunction syndrome in severely traumatic patients]. He Z; Wang S; Su Z; Huang Y; Yang J Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):492-3. PubMed ID: 11829898 [TBL] [Abstract][Full Text] [Related]
33. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease]. Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100 [TBL] [Abstract][Full Text] [Related]
34. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Adachi K; Kumamoto T; Araki S Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855 [TBL] [Abstract][Full Text] [Related]
35. Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients. Hayashi H; Miura Y; Maeda M; Murakami S; Kumagai N; Nishimura Y; Kusaka M; Urakami K; Fujimoto W; Otsuki T Int J Immunopathol Pharmacol; 2010; 23(4):1099-109. PubMed ID: 21244759 [TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients. Lee S; Hayashi H; Kumagai-Takei N; Matsuzaki H; Yoshitome K; Nishimura Y; Uragami K; Kusaka M; Yamamoto S; Ikeda M; Hatayama T; Fujimoto W; Otsuki T Exp Ther Med; 2017 Jun; 13(6):2616-2622. PubMed ID: 28587321 [TBL] [Abstract][Full Text] [Related]
38. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932 [TBL] [Abstract][Full Text] [Related]
39. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation]. Lis AD; Brzezińska-Wcisło LA Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159 [TBL] [Abstract][Full Text] [Related]
40. Decreased renal excretion of soluble interleukin-2 receptor alpha after treatment with daclizumab. ter Meulen CG; Göertz JH; Klasen IS; Verweij CM; Hilbrands LB; Wetzels JF; Hoitsma AJ Kidney Int; 2003 Aug; 64(2):697-703. PubMed ID: 12846768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]